Executive Director
AbbVie
Irvine, California, United States
Dr. Swati Gupta is the Executive Director at AbbVie, in Irvine, California. She is with the company for last 13 years where she leads the Immunology group under Development Biological Sciences function. The group is providing guidance on risk assessment due to modulation of the immune system for therapeutics and devices with a focus on immunogenicity and safety. She has held various position at BMS and Eli Lilly and has more than twenty years of combined experience. Dr. Gupta received her Ph.D. degree in Biochemistry/Chemistry from University of Nebraska, Lincoln and did her post-doctoral training at the University of California School of Medicine, Irvine in the Department of Microbiology and Molecular Genetics. Dr. Gupta has several publications in peer-reviewed journals and is currently actively participating in IQ consortium for TALG- Gene, Cell and oligo therapy. She is also participating in AAPS Immunogenicity Risk Assessment community.
Disclosure information not submitted.
Tuesday, April 25, 2023
10:30 AM – 11:00 AM ET